Stay updated with breaking news from Ahodwo Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A Ghanaian Pediatric Haematologist at Toronto, Canada Prof. Isaac Odame has called on the government to ensure that the National Health Insurance Scheme (NHIS) covers Hydroxyurea, a drug used for the treatment of sickle cell in the country. | Pulse Ghana
A Ghanaian Pediatric Haematologist at Toronto, Canada Prof. Isaac Odame has called on the government to ensure that the National Health Insurance Scheme (NHIS) covered Hydroxyurea, a drug used for the treatment of sickle cell in the country. That he said, would make the drug available to all across the…
A Ghanaian Pediatric Haematologist at Toronto, Canada Prof. Isaac Odame has called on the government to ensure that the National Health Insurance Scheme (NHIS) covered Hydroxyurea, a drug used for the treatment of sickle cell in the country. That he said, would make the drug available to all across…
On World Sickle Cell Day (19th June 2021) the Vice President of the Republic of Ghana, His Excellency Dr. Mahamudu Bawumia, announced through his Facebook and Instagram pages that hydroxyurea, a disease-modifying therapy for sickle cell disease (SCD) will now be provided under the National Health Insurance Scheme (NHIS) to improve the health of people living with SCD in Ghana. This announcement followed a meeting he convened on 8th June 2021, with stakeholders including Professor Kwaku Ohene-Frempong, President of the Sickle Cell Foundation of Ghana (Foundation), Hon. Kwaku Agyemang-Man...